Maxcyte MXCT
NASDAQ MXCT
$1.18 +0.02 (+1.72%)
At close: Sep 29, 2026 · 4:00 PM EDT

Maxcyte (MXCT) Restructuring Costs (2025)

Updated

Maxcyte's Restructuring Costs came in at $3.06 million for FY2025.

Analysis

Maxcyte (MXCT) Restructuring Costs (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Maxcyte 123.12 Mn 123.12 Mn 5.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.06 Mn
API Access

Maxcyte Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=MXCT&period=max&api_key=YOUR_API_KEY